A hospital based study to assess the prevalence of cardiovascular risk factors among patients of chronic plaque psoriasis
Keywords:Cardiovascular risk factors, Metabolic syndrome, Psoriasis
Background: Psoriasis is a chronic systemic inflammatory disease associated with several cardiometabolic co morbidities such as obesity, insulin resistance, dyslipidemia and hypertension, and with clinically significant increased risk of cardiovascular disease and cardiovascular mortality.
Methods: The study group included 110 patients with chronic plaque psoriasis and an equally sized age and sex matched control group. Cardiovascular disease (CVD) risk factors studied included hypertension, diabetes mellitus, obesity, dyslipidemia, smoking, heavy alcohol use and family history of CVD.
Results: Psoriatic patients had a significantly higher prevalence of alcohol use (p=0.014), current smokers (p= 0.023), impaired fasting glucose (p=0.032), central obesity based on waist circumference (p=0.008), central obesity based on waist hip ratio (p=0.020) and dyslipidemia (p=0.000).
Conclusions: Psoriasis patients have a unfavourable cardiovascular risk profile. Therefore these patients should undergo screening and treatment of various modifiable risk factors to reduce morbidity and mortality.
Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-50.
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735-41.
Singh G, Aneja SP. Cardiovascular comorbidity in psoriasis. Indian J Dermatol. 2011;56(5):553-6.
Gisondi P1, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital based case-control study. Br J Dermatol. 2007;157(1):68-73.
Nijsten T, Wakee M. Complexity of the association between psoriasis and comorbidities. J Invest Dermatol. 2009;129:1601-3.
Sharma D, Vatsa M, Lakshmy R, Narang R, Bahl VK, Gupta SK. Study of cardiovascular risk factors among tertiary hospital employees and their families. Indian Heart J. 2011;63(5):418-24.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
Genuth S, Alberti KG, Benett P. Follow up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;2003:3160-7.
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendation for physical activity, medical and surgical management. J Assoc Phys India. 2009;57:163-70.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. An Rheum Dis. 2005;64 Suppl 2:ii30-6.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-95.
Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol. 2007;57(2):347-54.
Zhang X, Wang H, Te-Shao H, Yang S, Wang F. Frequent use of tobacco and alcohol in Chinese psoriasis patients. Int J Dermatol. 2002;41(10);659-62.
Malhotra SK, Dhaliwal GS, Puri KJPS, Gambhir ML, Mahajan M. An insight into relationship between psoriasis and metabolic syndrome. Egyptian Dermatol Online J. 2011;7(2):5-16.
Saricaoglu H, Güllülü S, Bülbül Baskan E, Cordan J, Tunali S. Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol. 2003;17:414-7.
Ghiasi M, Nouri M, Abbasi A, Hatami P, Abbasi MA, Nourijelyani K. Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol. 2011;56 (5):533-6.
Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76(6):662-5.
Kimball AB, Wu Y. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol. 2009;48(11):1147-56.
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.
Mebazaa A, El Asmi M, Zidi W, Zayani Y, Cheikh Rouhou R, El Ounifi S, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol. 2011; 25:705-709.